1
|
Cytochromes P450 in biosensing and biosynthesis applications: Recent progress and future perspectives. Trends Analyt Chem 2023. [DOI: 10.1016/j.trac.2022.116791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
2
|
Enzymology on an Electrode and in a Nanopore: Analysis Algorithms, Enzyme Kinetics, and Perspectives. BIONANOSCIENCE 2022. [DOI: 10.1007/s12668-022-01037-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
3
|
Human Cytochrome P450 2C9 and Its Polymorphic Modifications: Electroanalysis, Catalytic Properties, and Approaches to the Regulation of Enzymatic Activity. Processes (Basel) 2022. [DOI: 10.3390/pr10020383] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The electrochemical properties of cytochrome P450 2C9 (CYP2C9) and polymorphic modifications P450 2C9*2 (CYP2C9*2) and P450 2C9*3 (CYP2C9*3) were studied. To analyze the comparative electrochemical and electrocatalytic activity, the enzymes were immobilized on electrodes modified with a membrane-like synthetic surfactant (didodecyldimethylammonium bromide (DDAB)). An adequate choice of the type of modified electrode was confirmed by cyclic voltammetry of cytochromes P450 under anaerobic conditions, demonstrating well-defined peaks of reduction and oxidation of the heme iron. The midpoint potential, Emid, of cytochrome P450 2C9 is −0.318 ± 0.01 V, and Emid = −0.324 ± 0.01 V, and Emid = −0.318 ± 0.03 V for allelic variant 2C9*2 and allelic variant 2C9*3, respectively. In the presence of substrate diclofenac under aerobic conditions, cytochrome P450 2C9 and its polymorphic modifications P450 2C9*2 and P450 2C9*3 exhibit catalytic properties. Stimulation of the metabolism of diclofenac by cytochrome P450 2C9 in the presence of antioxidant medications mexidol and taurine was shown.
Collapse
|
4
|
Kuzikov AV, Filippova TA, Masamrekh RA, Shumyantseva VV. Electrochemical determination of (S)-7-hydroxywarfarin for analysis of CYP2C9 catalytic activity. J Electroanal Chem (Lausanne) 2022. [DOI: 10.1016/j.jelechem.2021.115937] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
5
|
Rao Gajula SN, Pillai MS, Samanthula G, Sonti R. Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development. Bioanalysis 2021; 13:1355-1378. [PMID: 34517735 DOI: 10.4155/bio-2021-0132] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Assessment of drug candidate's potential to inhibit cytochrome P450 (CYP) enzymes remains crucial in pharmaceutical drug discovery and development. Both direct and time-dependent inhibition of drug metabolizing CYP enzymes by the concomitant administered drug is the leading cause of drug-drug interactions (DDIs), resulting in the increased toxicity of the victim drug. In this context, pharmaceutical companies have grown increasingly diligent in limiting CYP inhibition liabilities of drug candidates in the early stages and examining risk assessments throughout the drug development process. This review discusses different strategies and decision-making processes for assessing the drug-drug interaction risks by enzyme inhibition and lays particular emphasis on in vitro study designs and interpretation of CYP inhibition data in a stage-appropriate context.
Collapse
Affiliation(s)
- Siva Nageswara Rao Gajula
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Balanagar, Telangana, 50003, India
| | - Megha Sajakumar Pillai
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Balanagar, Telangana, 50003, India
| | - Gananadhamu Samanthula
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Balanagar, Telangana, 50003, India
| | - Rajesh Sonti
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Balanagar, Telangana, 50003, India
| |
Collapse
|
6
|
Shumyantseva VV, Agafonova LE, Bulko TV, Kuzikov AV, Masamrekh RA, Yuan J, Pergushov DV, Sigolaeva LV. Electroanalysis of Biomolecules: Rational Selection of Sensor Construction. BIOCHEMISTRY (MOSCOW) 2021; 86:S140-S151. [PMID: 33827405 DOI: 10.1134/s0006297921140108] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Methods of electrochemical analysis of biological objects based on the reaction of electro-oxidation/electro-reduction of molecules are presented. Polymer nanocomposite materials that modify electrodes to increase sensitivity of electrochemical events on the surface of electrodes are described. Examples of applications electrochemical biosensors constructed with nanocomposite material for detection of biological molecules are presented, advantages and drawbacks of different applications are discussed.
Collapse
Affiliation(s)
- Victoria V Shumyantseva
- Laboratory of Bioelectrochemistry, Orekhovich Research Institute of Biomedical Chemistry, Moscow, 119992, Russia. .,Department of Biochemistry, Pirogov Russian National Research Medical University, Moscow, 117997, Russia
| | - Lubov E Agafonova
- Laboratory of Bioelectrochemistry, Orekhovich Research Institute of Biomedical Chemistry, Moscow, 119992, Russia
| | - Tatiana V Bulko
- Laboratory of Bioelectrochemistry, Orekhovich Research Institute of Biomedical Chemistry, Moscow, 119992, Russia
| | - Alexey V Kuzikov
- Laboratory of Bioelectrochemistry, Orekhovich Research Institute of Biomedical Chemistry, Moscow, 119992, Russia.,Department of Biochemistry, Pirogov Russian National Research Medical University, Moscow, 117997, Russia
| | - Rami A Masamrekh
- Laboratory of Bioelectrochemistry, Orekhovich Research Institute of Biomedical Chemistry, Moscow, 119992, Russia.,Department of Biochemistry, Pirogov Russian National Research Medical University, Moscow, 117997, Russia
| | - Jiayin Yuan
- Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, 10691, Sweden
| | - Dmitry V Pergushov
- Faculty of Chemistry, Lomonosov Moscow State University, Moscow, 117991, Russia
| | - Larisa V Sigolaeva
- Laboratory of Bioelectrochemistry, Orekhovich Research Institute of Biomedical Chemistry, Moscow, 119992, Russia.,Faculty of Chemistry, Lomonosov Moscow State University, Moscow, 117991, Russia
| |
Collapse
|
7
|
Makhova AA, Shikh EV, Bulko TV, Gilep AA, Usanov SA, Shumyantseva VV. No effect of lipoic acid on catalytic activity of cytochrome P450 3A4. Drug Metab Pers Ther 2020; 35:dmpt-2020-0105. [PMID: 32712589 DOI: 10.1515/dmpt-2020-0105] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Accepted: 05/13/2020] [Indexed: 01/10/2023]
Abstract
Objectives α-Lipoic acid is used as an antioxidant in multivitamin formulations to restore the normal level of intracellular glutathione after depletion caused by environmental pollutants or during physiological aging of the body, as a chelating agent, as a dietary supplement, in anti-aging compositions. Lipoic acid (LA) acts as a buffer in cancer therapy and in therapy of diseases associated with oxidative stress. The effect of LA on the catalytic functions of cytochrome P450 3A4 as the main enzyme of the biotransformation of drugs was studied. It was shown that LA in the concentration range of 50-200 μM affects the stage of electron transfer (stage of cytochrome P450 3A4 heme reduction), decreasing the cathodic reduction current by an average of 20 ± 5%. The kinetic parameters (k cat) of the N-demethylation reaction of erythromycin, the antibiotic of the macrolide group, used as a marker substrate for the comparative analysis of the catalytic activity of cytochrome P450 3A4, both in the presence of α-lipoic acid and in the cytochrome P450 3A4-erythromycin complex, amounted to comparable values of 3.5 ± 0.9 and 3.4 ± 0.9 min-1, respectively. Based on these experimental data, we can conclude that there is no significant effect of α-lipoic acid on the catalysis of cytochrome P450 3A4. These results can be projected on the possibility of using α-lipoic acid in complex therapy without negative impact on the enzymatic cytochrome P450 system. Methods The analysis was performed in electrochemical non-invasive model systems for recording the catalytic activity of cytochrome P450 3A4, using screen-printed electrodes, modified with membranous didodecyldimethylammonium bromide. Results It was shown that LA did not affect the N-demethylation of macrolide antibiotic erythromycin. Catalytic constant (k cat) of N-demethylation of erythromycin corresponds to 3.4 ± 0.9 min-1 and in the presence of LA corresponds to 3.5 ± 0.9 min-1. Conclusions Based on the obtained experimental data, we can conclude that there is no significant effect of α-lipoic acid on individual stages and processes of catalysis of cytochrome P450 3A4. LA can be recommended for inclusion in complex therapy as an antioxidant, antitoxic and chelating compound without negative impact on the enzymatic cytochrome P450 3A4 activity of the human body.
Collapse
Affiliation(s)
- Anna A Makhova
- Sechenov First Moscow State Medical University, Moscow, Russian Federation
| | - Evgeniya V Shikh
- Sechenov First Moscow State Medical University, Moscow, Russian Federation
| | - Tatiana V Bulko
- Institute of Biomedical Chemistry, Moscow, Russian Federation
| | | | | | - Victoria V Shumyantseva
- Institute of Biomedical Chemistry, Moscow, Russian Federation.,Pirogov Russian National Research Medical University, Moscow, Russian Federation
| |
Collapse
|
8
|
All-electrochemical nanocomposite two-electrode setup for quantification of drugs and study of their electrocatalytical conversion by cytochromes P450. Electrochim Acta 2020. [DOI: 10.1016/j.electacta.2019.135579] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
9
|
Makhova AA, Shikh EV, Bulko TV, Sizova ZM, Shumyantseva VV. The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers. Drug Metab Pers Ther 2019; 34:dmpt-2019-0013. [PMID: 31603853 DOI: 10.1515/dmpt-2019-0013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Accepted: 08/16/2019] [Indexed: 12/21/2022]
Abstract
Background Cytochrome P450s (CYPs, EC 1.14.14.1) are the main enzymes of drug metabolism. The functional significance of CYPs also includes the metabolism of foreign chemicals and endogenic biologically active compounds. The CYP3A4 isoform contributes to the metabolism of about half of all marketed medicinal preparations. The aim of this study was to investigate the effects of two biologically active compounds: 2-aminoethane-sulfonic acid (taurine) and 3-hydroxy-4-trimethylaminobutyrate (L-carnitine) on urinary 6β-hydroxycortisol/cortisol (6β-OHC/cortisol) metabolic ratio as a biomarker of the CYP3A4 activity of healthy volunteers. Taurine is used for the treatment of chronic heart failure and liver disease. Cardiologists, nephrologists, neurologists, gerontologists in addition to the main etiopathogenetic therapies, use L-carnitine. The quantification of the 6β-OHC/cortisol metabolic ratio as a biomarker of CYP3A4 activity in human urine was used for the assessment of CYP3A4 catalytic activity as a non-invasive test. Methods The study included 18 healthy male volunteers (aged from 18 to 35 years old). The volunteers took taurine in a dose of 500 mg twice a day or L-carnitine in a dose of 2.5 mL 3 times a day for 14 consecutive days. The test drug was given 20 min before meals. The collection of urine samples was performed before and after 3, 7, 10, and 14 days after taurine intake. The metabolic ratio of 6β-OHC/cortisol in morning spot urine samples was studied by the liquid chromatography/mass spectroscopy (LC/MS) method. Results The ratio of 6-6β-OHC/cortisol was used as a biomarker to study the taurine and L-carnitine influence on CYP3A4 metabolism of cortisol. The ratio of urinary 6β-OCH/cortisol in the morning urine samples of volunteers before the beginning of taurine therapy (baseline ratio) was 2.71 ± 0.2. Seven days after the administration of taurine in a dose of 500 mg twice a day, the 6β-OCH/cortisol ratio was 3.3 ± 0.2, which indicated the increased catalytic activity of CYP3A4 towards cortisol. As for the L-carnitine supplementation, analysis of the 6β-OCH/cortisol ratio in the urine for 14 days did not show any significant changes in this baseline ratio, indicating the lack of L-carnitine influence on the catalytic activity of CYP3A4 to cortisol. Conclusions The results obtained demonstrated the influence of taurine on 6β-OCH/cortisol metabolic ratio as a biomarker of CYP3A4 catalytic activity to cortisol. L-carnitine did not affect the activity of CYP3A4. The lack of a clinically meaningful effect of L-carnitine was established.
Collapse
Affiliation(s)
- Anna A Makhova
- I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | - Eugenia V Shikh
- I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | | | - Zhanna M Sizova
- I.M. Sechenov First Moscow State Medical University, Moscow, Russia
| | | |
Collapse
|
10
|
Masamrekh RA, Kuzikov AV, Haurychenka YI, Shcherbakov KA, Veselovsky AV, Filimonov DA, Dmitriev AV, Zavialova MG, Gilep AA, Shkel TV, Strushkevich NV, Usanov SA, Archakov AI, Shumyantseva VV. In vitro
interactions of abiraterone, erythromycin, and CYP3A4: implications for drug–drug interactions. Fundam Clin Pharmacol 2019; 34:120-130. [DOI: 10.1111/fcp.12497] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Revised: 06/12/2019] [Accepted: 07/04/2019] [Indexed: 02/06/2023]
Affiliation(s)
- Rami A. Masamrekh
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
- Pirogov Russian National Research Medical University Ostrovityanova Street, 1 Moscow 117997 Russia
| | - Alexey V. Kuzikov
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
- Pirogov Russian National Research Medical University Ostrovityanova Street, 1 Moscow 117997 Russia
| | - Yaraslau I. Haurychenka
- Pirogov Russian National Research Medical University Ostrovityanova Street, 1 Moscow 117997 Russia
| | - Kirill A. Shcherbakov
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
| | | | - Dmitrii A. Filimonov
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
| | - Alexander V. Dmitriev
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
| | - Maria G. Zavialova
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
| | - Andrei A. Gilep
- Institute of Bioorganic Chemistry NASB 5 Academician V.F. Kuprevich Street, Build 2 Minsk BY‐220141 Belarus
| | - Tatsiana V. Shkel
- Institute of Bioorganic Chemistry NASB 5 Academician V.F. Kuprevich Street, Build 2 Minsk BY‐220141 Belarus
| | - Natallia V. Strushkevich
- Institute of Bioorganic Chemistry NASB 5 Academician V.F. Kuprevich Street, Build 2 Minsk BY‐220141 Belarus
| | - Sergey A. Usanov
- Institute of Bioorganic Chemistry NASB 5 Academician V.F. Kuprevich Street, Build 2 Minsk BY‐220141 Belarus
| | - Alexander I. Archakov
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
- Pirogov Russian National Research Medical University Ostrovityanova Street, 1 Moscow 117997 Russia
| | - Victoria V. Shumyantseva
- Institute of Biomedical Chemistry Pogodinskaya Street, 10, Build 8 Moscow 119121 Russia
- Pirogov Russian National Research Medical University Ostrovityanova Street, 1 Moscow 117997 Russia
| |
Collapse
|
11
|
Shumyantseva VV, Makhova AA, Shikh EV, Bulko TV, Kuzikov AV, Masamrekh RA, Shkel T, Usanov S, Gilep A, Archakov AI. Bioelectrochemical Systems as Technologies for Studying Drug Interactions Related to Cytochrome P450. BIONANOSCIENCE 2018. [DOI: 10.1007/s12668-018-0567-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
12
|
From electrochemistry to enzyme kinetics of cytochrome P450. Biosens Bioelectron 2018; 121:192-204. [PMID: 30218927 DOI: 10.1016/j.bios.2018.08.040] [Citation(s) in RCA: 43] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 08/02/2018] [Accepted: 08/17/2018] [Indexed: 12/23/2022]
Abstract
This review is an attempt to describe advancements in the electrochemistry of cytochrome P450 enzymes (EC 1.14.14.1) and to study molecular aspects and catalytic behavior of enzymatic electrocatalysis. Electroanalysis of cytochrome P450 demonstrates how to translate theoretical laws and equations of classical electrochemistry for the calculation of the kinetic parameters of enzymatic reactions and then translation of kinetic parameters to interpretation of drug-drug interactions. The functional significance of cytochrome P450s (CYPs) includes the metabolism of drugs, foreign chemicals, and endogenic compounds. The pharmaceutical industry needs sensitive and cost-effective systems for screening new drugs and investigation of drug-drug interactions. The development of different types of CYP-based biosensors is now in great demand. This review also highlights the characteristics of electrode processes and electrode properties for optimization of the cytochrome P450 electroanalysis. Electrochemical cytochrome P450-biosensors are the most studied. In this review, we analyzed electrode/cytochrome P450 systems in terms of the mechanisms underlying P450-catalyzed reactions. Screening of potential substrates or inhibitors of cytochromes P450 by means of electrodes were described.
Collapse
|
13
|
Nerimetla R, Premaratne G, Liu H, Krishnan S. Improved electrocatalytic metabolite production and drug biosensing by human liver microsomes immobilized on amine-functionalized magnetic nanoparticles. Electrochim Acta 2018. [DOI: 10.1016/j.electacta.2018.05.085] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
14
|
Abstract
Electrochemistry has emerged as a powerful analytical technique for chemical analysis of living cells, biologically active molecules and metabolites. Electrochemical biosensor, microfluidics and mass spectrometry are the most frequently used methods for electrochemical detection and monitory, which comprise a collection of extremely useful measurement tools for various fields of biology and medicine. Most recently, electrochemistry has been shown to be coupled with nanotechnology and genetic engineering to generate new enabling technologies, providing rapid, selective, and sensitive detection and diagnosis platforms. The primary focus of this review is to highlight the utility of electrochemical strategies and their conjunction with other approaches for drug metabolism and discovery. Current challenges and possible future developments and applications of electrochemistry in drug studies are also discussed.
Collapse
|